This website uses cookies
Read our Privacy policy and Terms of use for more information.
All our content on the Tandem Diabetes t:slim X2 insulin pump and how people use it for diabetes management.
News
+4
/
Aug 11, 2026
The insulin pump company is expanding access to pumps by tapping into new European markets and offering pay-as-you-go benefit options for U.S. customers.
CGM
Jul 1, 2026
Control-IQ+ users in the UK, Switzerland, Sweden, Finland, and Italy get a new CGM option with more countries expected to follow in 2026.
Jun 8, 2026
Backed by two major clinical trials, Tandem's t:slim X2 and Tandem Mobi are now approved in Europe for use during pregnancy and in type 2 diabetes.
Dexcom
+3
May 4, 2026
The integration brings Dexcom's newest and longest-lasting CGM to the t:slim X2 automated insulin delivery system.
+5
Apr 27, 2026
Tandem's Control IQ+ becomes the only commercially available automated insulin delivery system approved for pregnancy use in the U.S.
Feb 23, 2026
The new model is meant to lower upfront costs and expand access, joining the broader industry move toward subscription-style pump access through pharmacies.
Oct 29, 2025
All U.S. t:slim X2 users have access to FreeStyle Libre 3 Plus CGM integration, with international early-access programs rolling out later this year.
Oct 22, 2025
Tandem Diabetes Care confirms upcoming compatibility between the t:slim X2 insulin pump and the FreeStyle Libre 3 Plus sensor this year.
Sep 30, 2025
FDA clears Tandem’s t:slim X2 insulin pump for use with Lilly’s ultra-rapid Lyumjev insulin, expanding options beyond Humalog and Novolog.
Tandem
Dec 9, 2024
I spoke with a user of the t:slim X2 about how well it works for diabetes management from its Control-IQ algorithm, Dexcom CGM compatibility, and the t:connect app.